Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.”

7 pharma patents match "SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.” · 30,257 patents in full index Clear search

  1. US 12384853

    Anti-HER2/PD1 bispecific antibody

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. US 12319748

    Antibody binding to human HER2 and preparation method and use thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  3. US 12269886

    Tetravalent bispecific antibody against PD-1 and PD-L1

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  4. US 11667717

    Antibodies binding to human IL-4R, preparation method therefor and use thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  5. US 11370836

    Monoclonal antibody binding to human IL-5, preparation method therefor and use thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  6. US 11254746

    Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  7. US 10738112

    Anti-human interleukin-17A monoclonal antibody

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted